N. Ohtake et al., Modulation of lung local immune responses by oral administration of a herbal medicine Sho-saiko-to, INT J IMMUN, 22(6), 2000, pp. 419-430
Sho-saiko-to (SST), a Chinese/Japanese herbal medicine (Kampo medicine) wid
ely used to treat chronic hepatitis in Japan, is known to modulate immune r
esponses, and thus its immunomodulating activity may be responsible for its
bi-directional effects on the lungs as therapeutic efficacy in various lun
g diseases and involvement in development of interstitial pneumonia. We adm
inistered SST to BALB/c mice orally and examined the lung tissue levels of
pro/ anti-inflammatory cytokines, interleukin-1beta (IL-1 beta), tumor necr
osis factor-alpha (TNF-alpha) and interleukin-6 (IL-6), and the effects of
SST on acute lung injury induced by instillation of lipopolysaccharide (LPS
) or IL-1. Although SST had no effect on lung TNF-alpha or IL-1 beta level,
it increased IL-6. Investigation of active fractions of SST suggested that
multiple ingredients were supposed to be responsible for IL-6-inducing act
ivity. Liquiritigenin, a metabolite of liquiritin which is one of the major
ingredients in SST enhanced in vitro IL-6 production in anti-CD3 monoclona
l antibody (anti-CD3 mAb)-stimulated lung mononuclear cells in a cell-type
specific and dose-dependent manner. SST suppressed LPS-induced lung injury
at the later phase when lung leak was evident while being ineffective on in
itial neutrophil sequestration to the lung in these models. These findings
suggest that SST modulates lung inflammation by regulating local immune res
ponse. (C) 2000 International Society for Immunopharmacology. Published by
Elsevier Science Ltd. All rights reserved.